ImmuneHealth

ImmuneHealth is a flexible structure able to design, set-up, recruit, conduct epidemiology studies and provide immunomonitoring readouts. They have access to Human Biological Samples of various types (blood, urine, saliva, biopsies…), and supply generic (biobank retrospective approach) or custom fresh ones on demand (prospective approach with access to subset populations). ImmuneHealth is able to provide QC methods with development from scratch, testing, qualification, validation, technical transfer, consulting and training activies through ELISA, ELISpot, Multiplex, rt(q)PCR, sequencing, pyrosequencing, FACS, ICS, microneutralization, binding assays, CAPS… ImmuneHealth’s laboratories are ISO, GCLP compliant and currently work on GMP certification to ensure release tests by mid-2013. ImmuneHealth is a Centre Agree de Recherche and consequently a non-lucrative entity bridging the gap between R&D fundamental and clinical research, and translates basic immunology into medicine. Their versatile structure is able to provide proof of concept for new products and to discover and validate immunobiomarker panels. ImmuneHealth is currently engaged into several European and regional projects (FEDER, FP6, FP7…) developing its own portfolio with a related network in the diagnostic and theranostic field. Among their partners, they count GSK Vaccines, Biocygnus, Pevion, Genticel, Neovacs, Cardio3, MaSTherCell…